학술논문
Use of Flutemetamol F 18–Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment.
Document Type
Article
Author
Wolk, David A.; Sadowsky, Carl; Safirstein, Beth; Rinne, Juha O.; Duara, Ranjan; Perry, Richard; Agronin, Marc; Gamez, Jose; Shi, Jiong; Ivanoiu, Adrian; Minthon, Lennart; Walker, Zuzana; Hasselbalch, Steen; Holmes, Clive; Sabbagh, Marwan; Albert, Marilyn; Fleisher, Adam; Loughlin, Paul; Triau, Eric; Frey, Kirk
Source
JAMA Neurology; Sep2018, Vol. 75 Issue 9, p1114-1123, 10p
Subject
Language
ISSN
21686149